 Michael Tchou
Concepts (119)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hospitals, Pediatric | 11 | 2022 | 479 | 1.370 |
Why?
| | Electrolytes | 2 | 2019 | 55 | 1.260 |
Why?
| | Unnecessary Procedures | 2 | 2019 | 43 | 1.230 |
Why?
| | Curriculum | 5 | 2018 | 845 | 0.930 |
Why?
| | Community-Acquired Infections | 2 | 2022 | 141 | 0.880 |
Why?
| | Laboratories, Hospital | 2 | 2019 | 13 | 0.820 |
Why?
| | Clinical Laboratory Techniques | 2 | 2019 | 87 | 0.770 |
Why?
| | Pneumonia, Bacterial | 1 | 2022 | 106 | 0.760 |
Why?
| | Pediatrics | 6 | 2022 | 984 | 0.730 |
Why?
| | Explosive Agents | 1 | 2020 | 9 | 0.710 |
Why?
| | Quality Improvement | 6 | 2022 | 954 | 0.710 |
Why?
| | Hospital Medicine | 1 | 2021 | 82 | 0.700 |
Why?
| | Medicine | 1 | 2021 | 102 | 0.690 |
Why?
| | Quality of Health Care | 4 | 2018 | 573 | 0.680 |
Why?
| | Incidental Findings | 1 | 2020 | 77 | 0.680 |
Why?
| | Pneumonia | 2 | 2022 | 568 | 0.680 |
Why?
| | Respiratory Tract Infections | 1 | 2022 | 321 | 0.620 |
Why?
| | Hospitalists | 1 | 2021 | 174 | 0.620 |
Why?
| | Education, Medical, Graduate | 2 | 2022 | 374 | 0.600 |
Why?
| | Internship and Residency | 3 | 2022 | 944 | 0.570 |
Why?
| | Child, Hospitalized | 3 | 2021 | 38 | 0.550 |
Why?
| | Education, Medical | 2 | 2018 | 222 | 0.520 |
Why?
| | Hospitalization | 7 | 2022 | 1754 | 0.460 |
Why?
| | Child | 18 | 2024 | 18366 | 0.450 |
Why?
| | Pandemics | 1 | 2021 | 1325 | 0.440 |
Why?
| | Cross-Sectional Studies | 8 | 2023 | 4407 | 0.360 |
Why?
| | Attitude of Health Personnel | 1 | 2017 | 978 | 0.360 |
Why?
| | Consumer Behavior | 2 | 2021 | 66 | 0.350 |
Why?
| | Staff Development | 2 | 2018 | 39 | 0.310 |
Why?
| | Patient Readmission | 3 | 2021 | 608 | 0.290 |
Why?
| | Surveys and Questionnaires | 2 | 2018 | 4635 | 0.280 |
Why?
| | Humans | 29 | 2024 | 114937 | 0.270 |
Why?
| | Faculty, Medical | 2 | 2018 | 232 | 0.260 |
Why?
| | Accreditation | 2 | 2022 | 78 | 0.230 |
Why?
| | Ascorbic Acid Deficiency | 1 | 2024 | 6 | 0.230 |
Why?
| | Scurvy | 1 | 2024 | 12 | 0.230 |
Why?
| | Infant | 6 | 2022 | 7937 | 0.220 |
Why?
| | Infant, Newborn | 4 | 2022 | 5035 | 0.220 |
Why?
| | Anti-Bacterial Agents | 3 | 2022 | 1477 | 0.220 |
Why?
| | Retrospective Studies | 9 | 2024 | 12544 | 0.210 |
Why?
| | Parents | 2 | 2021 | 1191 | 0.210 |
Why?
| | Seizures, Febrile | 1 | 2022 | 19 | 0.200 |
Why?
| | Cost of Illness | 2 | 2021 | 254 | 0.200 |
Why?
| | Patient Care Bundles | 1 | 2022 | 17 | 0.200 |
Why?
| | Communicable Diseases | 1 | 2023 | 130 | 0.190 |
Why?
| | Fluid Therapy | 1 | 2022 | 122 | 0.180 |
Why?
| | Hospital Costs | 1 | 2021 | 103 | 0.180 |
Why?
| | Meningitis | 1 | 2021 | 74 | 0.180 |
Why?
| | Focus Groups | 1 | 2022 | 385 | 0.170 |
Why?
| | Encephalitis | 1 | 2021 | 127 | 0.170 |
Why?
| | Infusions, Parenteral | 1 | 2019 | 36 | 0.170 |
Why?
| | Laboratories | 1 | 2020 | 95 | 0.170 |
Why?
| | Diarrhea | 1 | 2020 | 173 | 0.160 |
Why?
| | Soft Tissue Infections | 1 | 2019 | 30 | 0.160 |
Why?
| | Administration, Intravenous | 1 | 2019 | 125 | 0.160 |
Why?
| | Gram-Positive Bacteria | 1 | 2018 | 45 | 0.160 |
Why?
| | Gastroenteritis | 1 | 2019 | 65 | 0.150 |
Why?
| | Bacteriological Techniques | 1 | 2018 | 65 | 0.150 |
Why?
| | Ohio | 1 | 2018 | 135 | 0.150 |
Why?
| | Molecular Diagnostic Techniques | 1 | 2018 | 92 | 0.150 |
Why?
| | Drug Resistance, Bacterial | 1 | 2018 | 155 | 0.150 |
Why?
| | Hospitals | 1 | 2022 | 581 | 0.140 |
Why?
| | Bacteremia | 1 | 2018 | 159 | 0.140 |
Why?
| | Anti-Infective Agents | 1 | 2019 | 225 | 0.140 |
Why?
| | Length of Stay | 4 | 2023 | 949 | 0.140 |
Why?
| | Drug Costs | 1 | 2017 | 91 | 0.140 |
Why?
| | Data Interpretation, Statistical | 1 | 2018 | 323 | 0.130 |
Why?
| | Health Care Costs | 1 | 2019 | 380 | 0.130 |
Why?
| | Delivery of Health Care | 2 | 2018 | 834 | 0.120 |
Why?
| | Acute Kidney Injury | 1 | 2021 | 638 | 0.120 |
Why?
| | Child, Preschool | 4 | 2022 | 9086 | 0.120 |
Why?
| | Amiodarone | 1 | 2014 | 23 | 0.120 |
Why?
| | Hypertrophy, Left Ventricular | 1 | 2014 | 103 | 0.110 |
Why?
| | Anti-Arrhythmia Agents | 1 | 2014 | 106 | 0.110 |
Why?
| | Learning | 1 | 2017 | 352 | 0.110 |
Why?
| | Biomedical Research | 1 | 2018 | 585 | 0.100 |
Why?
| | Clinical Competence | 1 | 2018 | 901 | 0.100 |
Why?
| | Tomography, X-Ray Computed | 1 | 2020 | 2326 | 0.090 |
Why?
| | Decision Making | 1 | 2017 | 781 | 0.090 |
Why?
| | Atrial Fibrillation | 1 | 2014 | 325 | 0.090 |
Why?
| | Adolescent | 4 | 2022 | 17829 | 0.090 |
Why?
| | Practice Patterns, Physicians' | 1 | 2018 | 1177 | 0.080 |
Why?
| | United States | 3 | 2021 | 12211 | 0.080 |
Why?
| | Health Expenditures | 2 | 2019 | 171 | 0.070 |
Why?
| | Asthma | 1 | 2017 | 2042 | 0.060 |
Why?
| | Male | 5 | 2022 | 55663 | 0.060 |
Why?
| | Ascorbic Acid | 1 | 2024 | 110 | 0.050 |
Why?
| | Female | 5 | 2022 | 59581 | 0.050 |
Why?
| | Reference Standards | 1 | 2022 | 159 | 0.050 |
Why?
| | Benchmarking | 1 | 2022 | 161 | 0.050 |
Why?
| | Cluster Analysis | 1 | 2022 | 460 | 0.040 |
Why?
| | Income | 1 | 2020 | 167 | 0.040 |
Why?
| | Health Surveys | 1 | 2021 | 443 | 0.040 |
Why?
| | Cost Savings | 1 | 2018 | 74 | 0.040 |
Why?
| | Los Angeles | 1 | 2018 | 56 | 0.040 |
Why?
| | Education | 1 | 2018 | 95 | 0.040 |
Why?
| | Insurance Coverage | 1 | 2019 | 202 | 0.040 |
Why?
| | Microbial Sensitivity Tests | 1 | 2018 | 301 | 0.040 |
Why?
| | Coinfection | 1 | 2018 | 120 | 0.040 |
Why?
| | Poverty | 1 | 2020 | 443 | 0.040 |
Why?
| | Health Services Research | 1 | 2018 | 371 | 0.030 |
Why?
| | Cost-Benefit Analysis | 1 | 2018 | 546 | 0.030 |
Why?
| | Inpatients | 1 | 2019 | 380 | 0.030 |
Why?
| | Kidney | 1 | 2021 | 1184 | 0.030 |
Why?
| | Acute Disease | 1 | 2017 | 915 | 0.030 |
Why?
| | Combined Modality Therapy | 1 | 2017 | 1126 | 0.030 |
Why?
| | Young Adult | 2 | 2019 | 10478 | 0.030 |
Why?
| | Anti-Asthmatic Agents | 1 | 2017 | 350 | 0.030 |
Why?
| | Critical Care | 1 | 2017 | 474 | 0.030 |
Why?
| | Magnetic Resonance Imaging | 1 | 2024 | 3053 | 0.030 |
Why?
| | Reproducibility of Results | 1 | 2018 | 2770 | 0.020 |
Why?
| | Survival Analysis | 1 | 2014 | 1220 | 0.020 |
Why?
| | Disease Progression | 1 | 2017 | 2392 | 0.020 |
Why?
| | Time Factors | 1 | 2019 | 6125 | 0.020 |
Why?
| | Adult | 2 | 2019 | 30608 | 0.020 |
Why?
| | Middle Aged | 2 | 2019 | 26806 | 0.020 |
Why?
| | Emergency Service, Hospital | 1 | 2017 | 1813 | 0.020 |
Why?
| | Cohort Studies | 1 | 2014 | 4903 | 0.010 |
Why?
| | Aged | 1 | 2014 | 19122 | 0.010 |
Why?
|
|
Tchou's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|